ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Therapy of conjunctivitis

Therapy of conjunctivitis
  Dose (each affected eye)
Empiric approach
Erythromycin 5 mg/gram ophthalmic ointment (preferred in noncontact lens wearers) 0.5 inch (1.25 cm) 4 times daily for 5 to 7 days
or
Trimethoprim-polymyxin B 0.1%-10,000 units/mL ophthalmic drops (preferred in noncontact lens wearers) 1 to 2 drops 4 times daily for 5 to 7 days
or
Ofloxacin 0.3% ophthalmic drops (preferred agent in contact lens wearer)* 1 to 2 drops 4 times daily for 5 to 7 days
or
Ciprofloxacin 0.3% ophthalmic drops (preferred agent in contact lens wearer)* 1 to 2 drops 4 times daily for 5 to 7 days
or
Ciprofloxacin 0.3% ophthalmic ointment (preferred agent in contact lens wearers)* 0.5 inch (1.25 cm) 2 or 3 times daily for 5 to 7 days
or
Fusidic acid 1% ophthalmic suspension (alternative for noncontact lens wearers; available in many areas other than United States) 1 drop 2 times daily for 7 days
Specific approach
Bacterial conjunctivitis
Erythromycin 5 mg/gram ophthalmic ointment (preferred in noncontact lens wearers) 0.5 inch (1.25 cm) 4 times daily for 5 to 7 days
or
Trimethoprim-polymyxin B 0.1%-10,000 units/mL ophthalmic drops (preferred in noncontact lens wearers) 1 to 2 drops 4 times daily for 5 to 7 days
or
Bacitracin-polymyxin B 500 units-10,000 units/gram ophthalmic ointment (alternative in noncontact lens wearers) 0.5 inch (1.25 cm) 4 to 6 times daily for 5 to 7 days
or
Bacitracin 500 units/gram ophthalmic ointment (alternative in noncontact lens wearers) 0.5 inch (1.25 cm) 4 to 6 times daily for 5 to 7 days
or
Ofloxacin 0.3% (preferred agent in contact lens wearers)* 1 to 2 drops 4 times daily for 5 to 7 days
or
Ciprofloxacin 0.3% ophthalmic drops (preferred agent in contact lens wearer)* 1 to 2 drops 4 times daily for 5 to 7 days
or
Ciprofloxacin 0.3% ophthalmic ointment (preferred agent in contact lens wearers)* 0.5 inch (1.25 cm) 2 or 3 times daily for 5 to 7 days
or
Azithromycin 1% ophthalmic drops (alternative for noncontact lens wearers) 1 drop 2 times daily for 2 days; then 1 drop daily for 5 days
or
Fusidic acid 1% ophthalmic suspension (alternative for noncontact lens wearers; available in many areas other than United States) 1 drop 2 times daily for 7 days
Viral conjunctivitisΔ
Antihistamine/decongestant drops (OTC) 1 to 2 drops 4 times daily as needed for no more than 3 weeks
Allergic conjunctivitisΔ
Antihistamine/decongestant drops (OTC) 1 to 2 drops 4 times daily as needed for no more than 2 weeks
or
Antihistamine/mast cell stabilizer drops Generally, 1 to 2 drops 1 to 3 times daily (regimens vary by medication)
Non-specific conjunctivitis
Eye lubricant drops (OTC) 1 to 2 drops up to 6 times daily as needed
and/or
Eye lubricant ointment (OTC) 0.5 inch (1.25 cm) at bedtime or 4 times daily as needed

This table is intended for use in conjunction with UpToDate content on conjunctivitis. Some clinical presentations warrant prompt urgent referral to an ophthalmologist; warning signs may include decreased visual acuity, photophobia, severe pain, worsening symptoms after 1 day, or no response within a few days (except viral conjunctivitis which may worsen for 3 to 5 days); refer to topic.

Dosage regimens listed may differ from manufacturer's recommendations.

OTC: over-the-counter (available without a prescription in the United States).

* Patients should discontinue contact lens use until there is no discharge for 24 hours after completion of therapy; used lenses and lens case should be discarded. If there is any corneal opacity or suspicion of keratitis, the patient should be evaluated by an ophthalmologist. Other available ophthalmic fluoroquinolones include levofloxacin 1.5% and moxifloxacin 0.5% solutions.

¶ In some countries, topical chloramphenicol is an option.

Δ Eye lubricant drops and/or ointment may be beneficial for mild symptoms.

◊ OTC available ophthalmic solutions include:
  • Antihistamine/decongestant: Naphazoline-pheniramine
  • Antihistamine/mast cell stabilizer: Alcaftadine, ketotifen, olopatadine
  • Eye lubricants: Polyethylene glycol, propylene glycol, glycerin, others; a preservative-free formulation is preferred
Courtesy of Deborah S. Jacobs, MD with additional data from: The Wills Eye Manual, Chapter 5, "Conjunctiva/Sclera/Iris/External Disease," 8th ed, Gervasio K, Peck T eds, Philadelphia, PA: Lippincott Williams & Wilkins, 2022.
Graphic 55299 Version 14.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟